Metastatic Pancreatic Adenocarcinoma
Oncology·MeSH: Pancreatic Neoplasms
5 drugs in development·2 companies·14 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ARM C FOLFIRI | IGM Biosciences, Inc. (IGMS) |
Phase 2(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| avelumab | VACCINEX, INC. (VCNX) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Pancreatic Adenocarcinoma?
BioSniper tracks 5 drugs in development for Metastatic Pancreatic Adenocarcinoma across 2 companies.
How many clinical trials target Metastatic Pancreatic Adenocarcinoma?
There are 14 clinical trials targeting Metastatic Pancreatic Adenocarcinoma tracked by BioSniper.
Deep-dive into Metastatic Pancreatic Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis